Charming Medical (MCTA) Current Deferred Revenue (2025 - 2026)
Charming Medical (MCTA) posted Current Deferred Revenue of $3.0 million for Q1 2026, down 18.03% sequentially from $3.7 million in Q3 2025, and down 12.01% YoY from $3.5 million in Q1 2025.
Charming Medical (MCTA) Current Deferred Revenue (2025 - 2026) Analysis & Trends
Charming Medical has reported Current Deferred Revenue for 2 years, with the latest figure at $3.0 million in Q1 2026.
- Quarterly Current Deferred Revenue fell 12.01% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 million (down 12.01% YoY) and the FY2026 annual result came in at $3.0 million, down 12.01% from the prior year.
- Current Deferred Revenue fell to $3.0 million in Q1 2026 per MCTA's latest filing, from $3.7 million in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $3.7 million in Q3 2025 and troughed at $3.0 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn |
| 10 | Charming Medical | 445.47 Mn | 439.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.05 Mn |
| Sep 30, 2025 | 3.72 Mn |
| Mar 31, 2025 | 3.46 Mn |